292 filings
Page 4 of 15
S-8
aqf5n9ah09waj lwukt
4 Aug 21
Registration of securities for employees
4:32pm
8-K
me4yi0xwr8hwoj
28 Jul 21
Lantheus Holdings, Inc. Reports Second Quarter 2021 Financial Results
7:44am
8-K
nky9ua8it
23 Jul 21
Departure of Directors or Certain Officers
10:09am
SD
vv3pm00ptl75pc5
28 May 21
Conflict minerals disclosure
4:31pm
8-K
mq9xvjf
27 May 21
Other Events
7:06am
8-K
33ljwsc
4 May 21
Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
7:38am
8-K
9aof5x4
29 Apr 21
Departure of Directors or Certain Officers
4:31pm
8-K
2f4jzaqh a57um
1 Apr 21
Departure of Directors or Certain Officers
8:42am
DEFA14A
sn1t8pb8z
18 Mar 21
Additional proxy soliciting materials
5:08pm
8-K
bdqta4h9
5 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
p0cuv hqlb6kgx7ftkk
25 Feb 21
Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results
4:08pm
8-K
28wvkt44p46x1
1 Feb 21
Other Events
7:00am
CT ORDER
2ggfkg8wdz1gfc9fe0dq
21 Dec 20
Confidential treatment order
3:23pm
8-K
v889ql9e
9 Dec 20
Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent
3:28pm
8-K
xj5e i7x3vzmssjqm
3 Dec 20
Transaction Extends Relationship with Strategic Partner
7:06am
8-K
koew65t n2mf
18 Nov 20
Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY® Room Temperature
4:19pm